- Author:
Hui WANG
1
;
Chang CUI
1
;
Shuang YANG
1
;
An YAO
1
;
Shuting WU
1
;
Xiaoyan YANG
1
;
Ling YE
1
;
Guoping YANG
1
;
Jie HUANG
1
;
Hui WANG
2
;
Chang CUI
2
;
Shuang YANG
2
;
An YAO
2
;
Shuting WU
2
;
Xiaoyan YANG
2
;
Ling YE
2
;
Guoping YANG
2
;
Jie HUANG
2
;
Zhi ZOU
3
;
Zhi TANG
3
;
Dongsheng OUYANG
3
Author Information
- Publication Type:Journal Article
- Keywords: Bioequivalence; LC-MS/MS; Pharmacokinetic; Solifenacin succinate
- From: Chinese Journal of Clinical Pharmacology and Therapeutics 2021;26(3):299-304
- CountryChina
- Language:Chinese
- Abstract: AIM: To evaluate the bioequivalence of the test and reference preparations of solifenacin succinate tablets administered once orally under fasting and fed conditions in Chinese healthy volunteers. METHODS: The study was designed as single-center, randomized, open, self-crossover and twenty four healthy volunteers were recruited respectively in fasting and fed conditions. Subjects were assigned to receive a single oral of the test or reference formulation per period at a dose of 10 mg. The plasma concentration of solifenacin was analyzed by LC-MS/MS. The major pharmacokinetic parameters were calculated by WinNonlin 7.0, then the bioequivalence was evaluated.RESULTS: The main pharmacokinetic parameters of a single oral solifenacin succinate under fasting condition for test and reference preparation were as follows: C